Intravenous Drug Use and Hepatitis C Virus in Iran

Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share this content! On (X network) By

Intravenous Drug Use and Hepatitis C Virus in Iran Publisher

Zobeiri M¹ ; Adibi P² ; Alavian SM³

Show Affiliations

1. Department of Internal Medicine, Kermanshah University of Medical Sciences, School of Medicine, Imam Reza Hospital, Kermanshah, Iran
2. Department of Gastroenterology, Isfahan University of Medical Sciences, Isfahan, Iran
3. Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Baqiyatallah University of Medical Sciences, Tehran, Iran

Source: Hepatitis Monthly Published:2012

Abstract

[No abstract available]

Related Docs

View other Related Docs

1. Intravenous Drug Use and Hepatitis C Virus in Iran, Hepatitis Monthly (2012)

2. Identification of Patients With Hepatitis C Virus Infection in Persons With Background of Intravenous Drug Use: The First Community Announcementbased Study From Iran, International Journal of Preventive Medicine (2012)

3. Isolation of Hepatitis C Virus in Norjizac Vials, Hepatitis Monthly (2010)

4. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)

5. The Experience of Hepatitis C Screening Among Prison Inmates With Drug Injection History, Journal of Isfahan Medical School (2011)

6. Hepatitis C in Intravenous Drug Users: Seroprevalence and Risk Factors, Journal of Isfahan Medical School (2011)

7. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)

8. Hepatitis C Virus in Iran: Epidemiology of an Emerging Infection, Archives of Iranian Medicine (2005)

Experts (# of related papers)

View all Related Experts

Peyman Adibi (8)

Nazila Kassaian (7)

Other Related Docs

9. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)

10. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)

11. Incarceration Is a Major Risk Factor for Blood-Borne Infection Among Intravenous Drug Users, Hepatitis Monthly (2011)

Style	Citing Format
MLA	Zobeiri M, Adibi P, Alavian SM. "Intravenous Drug Use and Hepatitis C Virus in Iran." Hepatitis Monthly, vol. 12, no. 1, 2012, pp. 9-10.
APA	Zobeiri M, Adibi P, Alavian SM (2012). Intravenous Drug Use and Hepatitis C Virus in Iran. Hepatitis Monthly, 12(1), 9-10.
Chicago	Zobeiri M, Adibi P, Alavian SM. "Intravenous Drug Use and Hepatitis C Virus in Iran." Hepatitis Monthly 12, no. 1 (2012): 9-10.
Harvard	Zobeiri M, Adibi P, Alavian SM (2012) 'Intravenous Drug Use and Hepatitis C Virus in Iran', Hepatitis Monthly, 12(1), pp. 9-10.
Vancouver	Zobeiri M, Adibi P, Alavian SM. Intravenous Drug Use and Hepatitis C Virus in Iran. Hepatitis Monthly. 2012;12(1):9-10.
BibTex	@article{ author = {Zobeiri M and Adibi P and Alavian SM}, title = {Intravenous Drug Use and Hepatitis C Virus in Iran}, journal = {Hepatitis Monthly}, volume = {12}, number = {1}, pages = {9-10}, year = {2012} }
RIS	TY - JOUR AU - Zobeiri M AU - Adibi P AU - Alavian SM TI - Intravenous Drug Use and Hepatitis C Virus in Iran JO - Hepatitis Monthly VL - 12 IS - 1 SP - 9 EP - 10 PY - 2012 ER -